06/26/2025
According to the Alzheimer's Association, 92% of Americans would want a medication to slow the progression of Alzheimer’s disease following a diagnosis. However, in order to make that possible, early diagnosis is critical. An early Alzheimer’s diagnosis allows a patient the opportunity to participate in clinical trials, a chance to prioritize their health, access to treatment options and ultimately, increased odds of benefiting from treatment.
With more than 55 million people worldwide living with Alzheimer's or another dementia, and two-thirds of Americans having at least one major potential risk factor for dementia, the positive impact early diagnosis can have is absolutely incredible!
Dr. Shane Weber – an interventional radiologist here at Lakeview Hospital – joined Fox 13's The PLACE Wednesday to discuss testing and treatment options for the disease.
WATCH: http://bit.ly/3IgonrS via FOX 13 News & Shauna Lake
"At Lakeview Hospital, we’ve developed a tracking system that allows us to collaborate with referring providers for Alzheimer’s patients being considered for one of these new treatments," Dr. Weber explained. "The system allows us to quickly get patients scheduled for the correct imaging exam, to allow providers to initiate treatment more immediately, as well as for us to closely monitor side effects of the treatment."
MountainStar Healthcare | HCA Healthcare
Over 7 million Americans are living with Alzheimer's disease. By 2050, this number is projected to rise to nearly 13 million.